Processa Pharmaceuticals Stock

Processa Pharmaceuticals P/B

The P/B (Price-to-Book Ratio) of Processa Pharmaceuticals (PCSA) as of Aug 8, 2026 is 3.11. In the previous year, P/B (Price-to-Book Ratio) was 1.06 — a change of 194.13% (higher).

P/B

3.11

YoY

194.13%

Last updated:

P/B (Price-to-Book Ratio) of Processa Pharmaceuticals is 2026 3.11 . P/B (Price-to-Book Ratio) of Processa Pharmaceuticals was 2025 1.06 . It decreases by 194.13% higher compared to the previous year.
Access this data via the Eulerpool API

Processa Pharmaceuticals Stock analysis

What does Processa Pharmaceuticals do? Processa Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Processa Pharmaceuticals stock

P/B (Price-to-Book Ratio) of Processa Pharmaceuticals is 3.11 in 2026.

P/B (Price-to-Book Ratio) of Processa Pharmaceuticals changed from 1.06 to 3.11, representing a 194.13% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Processa Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Processa Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Processa Pharmaceuticals

All Key Metrics — Processa Pharmaceuticals